-
Products are supplied strictly for laboratory and scientific research — not for human or veterinary use.
MOTS-c is a mitochondrial-derived peptide studied in relation to cellular energy sensing, stress responses and metabolic homeostasis. It is unusual because its sequence is encoded within mitochondrial genetic material rather than a conventional nuclear protein-coding gene.
Research and educational context only. MOTS-c is not an FDA-approved drug. Laboratory research materials are not intended for human or veterinary use, consumption, diagnosis or treatment.
MOTS-c is a 16-amino-acid mitochondrial-derived peptide. Experimental research has examined how endogenous MOTS-c may participate in communication between mitochondria, the nucleus and metabolically active tissues.
Preclinical work has explored cellular stress adaptation, glucose metabolism, insulin sensitivity, exercise responses and age-associated changes. These findings are hypothesis-generating. They do not establish that an experimental MOTS-c product improves weight, performance, longevity or disease outcomes in people.
Human studies have largely measured circulating or tissue-associated MOTS-c rather than establishing an approved therapeutic intervention. A small controlled exercise study found changes in mitochondrial-derived peptide measurements after endurance or resistance exercise. Observational and exploratory findings can identify associations, but they cannot establish causation, effective administration or long-term safety.
FDA lists MOTS-c among nominated bulk substances that may present significant safety risks in compounding, citing limited human exposure information, possible immunogenicity and characterization challenges. Advisory review or discussion does not constitute approval.
| Evidence | Interpretation |
|---|---|
| Cell and animal studies | Support mechanistic hypotheses, not human efficacy |
| Human observational studies | Show associations that require confirmation |
| Small exercise studies | Explore endogenous peptide responses under defined conditions |
| Approved therapeutic evidence | No FDA-approved MOTS-c drug |
No. They involve different biological pathways and evidence bases.
No.
No. Research-use materials are not intended for human or veterinary use.
